article 2022 Antilipidemic ezetimibe induces regression of endometriotic explants in a rat model of endometriosis with its anti-inflammatory and anti-angiogenic effects Naunyn-Schmiedeberg's archives of pharmacology ·doi:10.1007/s00210-022-02226-2